Lanzino Giuseppe, Fraser Kenneth, Kanaan Yassine, Wagenbach Anne
Department of Neurosurgery, Illinois Neurological Institute, University of Illinois College of Medicine at Peoria, Illinois 61637, USA.
J Neurosurg. 2006 Mar;104(3):344-9. doi: 10.3171/jns.2006.104.3.344.
The aim of this study was to analyze the therapeutic decision-making process and outcome in 100 consecutive patients with aneurysmal subarachnoid hemorrhage (SAH) treated since the completion of the International Subarachnoid Aneurysm Trial (ISAT). All patients were evaluated and treated by a neurosurgeon with subspecialty training in both cerebrovascular and neuroendovascular surgery.
One hundred consecutive patients with aneurysmal SAH who had been admitted within 1 week posthemorrhage and who had been treated using either surgical clip application or endovascular coil embolization were included in this analysis. All patients underwent a uniform perioperative protocol. All surviving patients were given a questionnaire to assess their modified Rankin Scale score (mRS) and to grade themselves at 6 months and 1 year postintervention. The cohort consisted of 73 women and 27 men with a mean age of 57.27 years (range 27-87 years). Twenty-nine percent of the patients had a World Federation of Neurosurgical Societies (WFNS) Grade IV or V SAH. Forty-seven patients underwent direct surgical clip application, 41 endovascular embolization, and 12 a combination of the two procedures. Good functional outcome--indicated by mRS scores of 0 to 2 after at least 6 months--was achieved in 71% of patients.
Data from the ISAT demonstrated a better functional outcome following endovascular embolization in a selected group of patients with aneurysmal SAH. In routine clinical practice, however, a significant number of patients still benefit from direct surgical clip ligation. Excellent functional results can be realized in a complementary clip ligation and coil occlusion practice in which each patient and aneurysm is evaluated and the two treatment modalities are used individually or, when needed, in combination.
本研究旨在分析自国际蛛网膜下腔动脉瘤试验(ISAT)完成后连续收治的100例动脉瘤性蛛网膜下腔出血(SAH)患者的治疗决策过程及治疗结果。所有患者均由一位在脑血管和神经血管内外科方面接受过专科培训的神经外科医生进行评估和治疗。
本分析纳入了100例连续的动脉瘤性SAH患者,这些患者在出血后1周内入院,采用手术夹闭或血管内弹簧圈栓塞治疗。所有患者均接受统一的围手术期方案。所有存活患者均接受问卷调查,以评估其改良Rankin量表评分(mRS),并在干预后6个月和1年对自身进行分级。该队列包括73名女性和27名男性,平均年龄为57.27岁(范围27 - 87岁)。29%的患者为世界神经外科协会联盟(WFNS)IV级或V级SAH。47例患者接受了直接手术夹闭,41例接受了血管内栓塞,12例接受了两种手术联合治疗。71%的患者获得了良好的功能结局,即至少6个月后mRS评分为0至2分。
ISAT的数据表明,在一组选定的动脉瘤性SAH患者中,血管内栓塞后的功能结局更好。然而,在常规临床实践中,仍有相当数量的患者从直接手术夹闭中获益。在互补的夹闭结扎和弹簧圈栓塞实践中,可以实现优异的功能结果,即对每例患者和动脉瘤进行评估,单独或在需要时联合使用两种治疗方式。